Altimmune, Inc. - Common Stock (ALT)

CUSIP: 02155H200

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
104,413,190
Total 13F shares
42,376,353
Share change
-1,831,764
Total reported value
$281,796,522
Put/Call ratio
56%
Price per share
$6.65
Number of holders
173
Value change
-$21,723,923
Number of buys
96
Number of sells
84

Quarterly Holders Quick Answers

What is CUSIP 02155H200?
CUSIP 02155H200 identifies ALT - Altimmune, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ALT - Altimmune, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
STATE STREET CORP
13F
Company
8.3%
8,649,270
$88,049,569 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
3.9%
4,042,226
$41,149,861 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
3%
3,128,728
$31,850,452 31 Mar 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.6%
2,750,000
$27,995,000 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
2.1%
2,211,948
$22,517,631 31 Mar 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.6%
1,709,304
$17,400,716 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.5%
1,590,150
$16,187,727 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
1,236,798
$12,592,285 31 Mar 2024
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.95%
993,516
$10,113,993 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.88%
916,254
$9,327,466 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.87%
913,000
$9,294,339 31 Mar 2024
13F
Portolan Capital Management, LLC
13F
Company
0.85%
887,255
$9,032,256 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.85%
882,628
$8,985,153 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.83%
861,415
$8,769,205 31 Mar 2024
13F
READYSTATE ASSET MANAGEMENT LP
13F
Company
0.79%
825,800
$8,406,644 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.71%
742,913
$7,562,855 31 Mar 2024
13F
Knoll Capital Management, LLC
13F
Company
0.54%
567,219
$5,774,289 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.48%
499,872
$5,088,697 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.47%
493,968
$5,028,595 31 Mar 2024
13F
UBS Group AG
13F
Company
0.47%
490,001
$4,988,210 31 Mar 2024
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.45%
470,000
$4,784,600 31 Mar 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.41%
432,666
$4,404,540 31 Mar 2024
13F
BBR PARTNERS, LLC
13F
Company
0.34%
358,513
$3,649,662 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.34%
354,350
$3,607,283 31 Mar 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.31%
326,777
$3,326,590 31 Mar 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.3%
309,459
$3,150,293 31 Mar 2024
13F
MOODY ALDRICH PARTNERS LLC
13F
Company
0.29%
307,318
$3,128,497 31 Mar 2024
13F
Timelo Investment Management Inc.
13F
Company
0.28%
294,095
$2,993,887 31 Mar 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.28%
288,273
$2,934,619 31 Mar 2024
13F
GERBER, LLC
13F
Company
0.27%
281,778
$2,868,500 31 Mar 2024
13F
ARDSLEY ADVISORY PARTNERS LP
13F
Company
0.26%
275,000
$2,799,500 31 Mar 2024
13F
Beirne Wealth Consulting Services, LLC
13F
Company
0.26%
272,800
$2,777,104 31 Mar 2024
13F
Ghost Tree Capital, LLC
13F
Company
0.24%
250,000
$2,545,000 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.22%
234,730
$2,389,551 31 Mar 2024
13F
Woodline Partners LP
13F
Company
0.21%
214,245
$2,181,014 31 Mar 2024
13F
Susquehanna Portfolio Strategies, LLC
13F
Company
0.2%
207,197
$2,109,265 31 Mar 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.18%
190,824
$1,942,588 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.18%
189,654
$1,930,678 31 Mar 2024
13F
IMC-Chicago, LLC
13F
Company
0.16%
165,607
$1,685,879 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.15%
156,914
$1,597,385 31 Mar 2024
13F
Lynwood Capital Management Inc.
13F
Company
0.14%
150,000
$1,527,000 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.14%
146,259
$1,488,000 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.14%
142,705
$1,452,737 31 Mar 2024
13F
PROFUND ADVISORS LLC
13F
Company
0.13%
134,842
$1,372,692 31 Mar 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.12%
121,137
$1,233,175 31 Mar 2024
13F
Campbell & CO Investment Adviser LLC
13F
Company
0.11%
110,213
$1,121,968 31 Mar 2024
13F
Pennant Investors, LP
13F
Company
0.11%
109,800
$1,117,764 31 Mar 2024
13F
Swiss National Bank
13F
Company
0.1%
106,000
$1,079,080 31 Mar 2024
13F
OMERS ADMINISTRATION Corp
13F
Company
0.1%
104,600
$1,064,828 31 Mar 2024
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.1%
103,500
$1,053,630 31 Mar 2024
13F

Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2024

As of 30 Jun 2024, Altimmune, Inc. - Common Stock (ALT) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,376,353 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, TANG CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Knoll Capital Management, LLC, and GOLDMAN SACHS GROUP INC. This page lists 174 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
166
Q2 2024 holders
173
Holder diff
7
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.